Wildcat DX, LLC Strengthens Its Healthcare Portfolio with Navis Clinical Laboratories Acquisition

Wildcat DX, LLC Acquires Navis Clinical Laboratories

In a significant development in the healthcare sector, Wildcat DX, LLC has announced its acquisition of Navis Clinical Laboratories, Inc., a prominent player in the diagnostic lab testing landscape. This acquisition aims to bolster Wildcat DX’s commitment to delivering top-quality healthcare services and reinforce its position in the market.

Wildcat DX, headquartered in Cleveland, is known for its innovative approach and robust management team. They are bringing a wealth of experience into this acquisition, which is expected to enhance the quality of services provided by Navis. With this transition, Dr. Damon Borg has been appointed as interim CEO of Navis, signaling a strong leadership direction intended to leverage existing strengths while fostering further innovations.

Navis Clinical Laboratories has built a stellar reputation over the years for its dedication to excellence and innovation in diagnostic testing. It has been committed to upholding high standards and delivering value to its customers, something that aligns seamlessly with Wildcat DX’s core values. Miro Kesic, the Managing Partner of Wildcat DX, expressed enthusiasm about this new chapter, stating,